Form 4: SunOpta CHRO Duzan Granted 22,251 Restricted Stock Units
Executive Equity Grant
SunOpta Inc.'s Chief Human Resources Officer, Danielle Marie Duzan, was granted 22,251 Restricted Stock Units, vesting over three years.
Summary
- Danielle Marie Duzan, Chief Human Resources Officer (CHRO) of SunOpta Inc. (STKL), was granted 22,251 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of STKL common stock.
- The grant date for these RSUs was February 9, 2026.
- The RSUs will vest in three equal annual installments, commencing on April 11, 2026.
- Vesting is contingent upon Ms. Duzan's continued employment with SunOpta Inc. through each respective vesting date.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine and positive corporate governance action, aligning executive interests with long-term shareholder value, without indicating any significant operational or financial changes.
Positives
- The grant of 22,251 Restricted Stock Units aligns the CHRO's interests with long-term shareholder value.
- The three-year vesting schedule encourages the retention of key management personnel.
- The use of a Rule 10b5-1(c) plan indicates a pre-planned and transparent transaction.
Negatives
- There is no immediate cash inflow for the reporting person from this grant.
- The ultimate value of the RSUs is subject to the future performance of SunOpta's stock price.
Risks
- The value of the Restricted Stock Units is tied to the future market price of SunOpta Inc. common stock, which can fluctuate.
- Vesting is contingent on continued employment, meaning the reporting person would forfeit unvested units upon termination.
Future Outlook
The filing itself does not contain forward-looking statements or guidance from the company, only details of an executive's equity grant.
Industry Context
StockSavvy.ai notes that equity grants, particularly Restricted Stock Units with multi-year vesting schedules, are a standard practice across various industries, including the food and beverage sector where SunOpta operates. These grants are designed to align executive incentives with long-term company performance and shareholder interests, fostering retention of key talent.
Comparison to Industry Standards
- The grant of RSUs to a Chief Human Resources Officer is a common compensation practice for executives in publicly traded companies, comparable to practices at peers like Ingredion Incorporated or Bunge Limited, which also utilize equity-based incentives to retain and motivate leadership.
- A three-year vesting schedule is typical for RSU grants, providing a balance between immediate incentive and long-term commitment, consistent with industry benchmarks for executive retention programs.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | Grant of 22,251 Restricted Stock Units to the Chief Human Resources Officer as part of the executive compensation plan. | 02/09/2026 | Aligns executive incentives with long-term shareholder value and promotes executive retention. |
Stakeholder Impact
- Shareholders: Potential positive impact through better alignment of executive interests with long-term company performance.
- Employees: May signal stability in executive leadership and a commitment to long-term growth.
Next Steps
- The Restricted Stock Units will vest in three equal annual installments beginning April 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 02/09/2026 | Date of grant for 22,251 Restricted Stock Units to Danielle Marie Duzan. |
| 02/11/2026 | Date the Form 4 was signed by Brett Koch, attorney-in-fact for Danielle Marie Duzan. |
| 04/11/2026 | Date the first of three equal annual installments of Restricted Stock Units begins to vest. |
Recommendation
holdThis Form 4 filing details a routine equity grant to a key executive, which is a standard compensation practice. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The grant aligns executive incentives with long-term shareholder value, which is generally a positive for corporate governance, but it's not a catalyst for a 'buy' or 'sell' decision.
Keywords
SunOpta, STKL, Restricted Stock Units, RSU, Executive Compensation, Form 4, Insider Transaction, Danielle Duzan, CHRO, Equity Grant, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.